Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Novel valosin-containing protein mutations associated with multisystem proteinopathy.

Al-Tahan S, Al-Obeidi E, Yoshioka H, Lakatos A, Weiss L, Grafe M, Palmio J, Wicklund M, Harati Y, Omizo M, Udd B, Kimonis V.

Neuromuscul Disord. 2018 Jun;28(6):491-501. doi: 10.1016/j.nmd.2018.04.007. Epub 2018 Apr 17.

PMID:
29754758
2.
3.

Time Course of Radiological Imaging and Variable Interindividual Symptoms in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated with p.Arg487His Mutation in the VCP Gene.

Hirano M, Yamagishi Y, Yanagimoto S, Saigoh K, Nakamura Y, Kusunoki S.

Eur Neurol. 2017;78(1-2):78-83. doi: 10.1159/000478906. Epub 2017 Jul 24.

PMID:
28738334
4.

Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy.

Al-Obeidi E, Al-Tahan S, Surampalli A, Goyal N, Wang AK, Hermann A, Omizo M, Smith C, Mozaffar T, Kimonis V.

Clin Genet. 2018 Jan;93(1):119-125. doi: 10.1111/cge.13095.

5.

Weighted Protein Interaction Network Analysis of Frontotemporal Dementia.

Ferrari R, Lovering RC, Hardy J, Lewis PA, Manzoni C.

J Proteome Res. 2017 Feb 3;16(2):999-1013. doi: 10.1021/acs.jproteome.6b00934. Epub 2017 Jan 12.

6.

In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.

Nalbandian A, Llewellyn KJ, Gomez A, Walker N, Su H, Dunnigan A, Chwa M, Vesa J, Kenney MC, Kimonis VE.

Mitochondrion. 2015 May;22:1-8. doi: 10.1016/j.mito.2015.02.004. Epub 2015 Feb 25.

PMID:
25724235
7.

Parkinsonian syndrome in familial frontotemporal dementia.

Siuda J, Fujioka S, Wszolek ZK.

Parkinsonism Relat Disord. 2014 Sep;20(9):957-64. doi: 10.1016/j.parkreldis.2014.06.004. Epub 2014 Jun 13. Review.

8.

Autophagy and apoptosis dysfunction in neurodegenerative disorders.

Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, Łos MJ.

Prog Neurobiol. 2014 Jan;112:24-49. doi: 10.1016/j.pneurobio.2013.10.004. Epub 2013 Nov 6. Review.

9.

ALS-associated protein FIG4 is localized in Pick and Lewy bodies, and also neuronal nuclear inclusions, in polyglutamine and intranuclear inclusion body diseases.

Kon T, Mori F, Tanji K, Miki Y, Toyoshima Y, Yoshida M, Sasaki H, Kakita A, Takahashi H, Wakabayashi K.

Neuropathology. 2014 Feb;34(1):19-26. doi: 10.1111/neup.12056. Epub 2013 Jul 29.

PMID:
23888880
10.

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis.

D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H.

Free Radic Biol Med. 2013 Dec;65:509-27. doi: 10.1016/j.freeradbiomed.2013.06.029. Epub 2013 Jun 21. Review.

11.

Valosin-containing protein immunoreactivity in tauopathies, synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease.

Mori F, Tanji K, Toyoshima Y, Sasaki H, Yoshida M, Kakita A, Takahashi H, Wakabayashi K.

Neuropathology. 2013 Dec;33(6):637-44. doi: 10.1111/neup.12050. Epub 2013 Jun 19.

PMID:
23782134
12.

Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Mehta SG, Khare M, Ramani R, Watts GD, Simon M, Osann KE, Donkervoort S, Dec E, Nalbandian A, Platt J, Pasquali M, Wang A, Mozaffar T, Smith CD, Kimonis VE.

Clin Genet. 2013 May;83(5):422-31. doi: 10.1111/cge.12000. Epub 2012 Oct 4.

13.

Phenotypic variability in three families with valosin-containing protein mutation.

Spina S, Van Laar AD, Murrell JR, Hamilton RL, Kofler JK, Epperson F, Farlow MR, Lopez OL, Quinlan J, DeKosky ST, Ghetti B.

Eur J Neurol. 2013 Feb;20(2):251-8. doi: 10.1111/j.1468-1331.2012.03831.x. Epub 2012 Aug 20.

14.

Mutational analysis of the VCP gene in Parkinson's disease.

Majounie E, Traynor BJ, Chiò A, Restagno G, Mandrioli J, Benatar M, Taylor JP, Singleton AB.

Neurobiol Aging. 2012 Jan;33(1):209.e1-2. doi: 10.1016/j.neurobiolaging.2011.07.011. Epub 2011 Sep 13.

15.

Valosin-containing protein mutation and Parkinson's disease.

Chan N, Le C, Shieh P, Mozaffar T, Khare M, Bronstein J, Kimonis V.

Parkinsonism Relat Disord. 2012 Jan;18(1):107-9. doi: 10.1016/j.parkreldis.2011.07.006. Epub 2011 Aug 3. No abstract available.

PMID:
21816654
16.

Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.

Manno A, Noguchi M, Fukushi J, Motohashi Y, Kakizuka A.

Genes Cells. 2010 Aug;15(8):911-22. doi: 10.1111/j.1365-2443.2010.01428.x. Epub 2010 Jul 5.

17.

Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression.

Koike M, Fukushi J, Ichinohe Y, Higashimae N, Fujishiro M, Sasaki C, Yamaguchi M, Uchihara T, Yagishita S, Ohizumi H, Hori S, Kakizuka A.

J Biol Chem. 2010 Jul 9;285(28):21736-49. doi: 10.1074/jbc.M109.099283. Epub 2010 Apr 21.

18.

Structure and interaction of ubiquitin-associated domain of human Fas-associated factor 1.

Song J, Park JK, Lee JJ, Choi YS, Ryu KS, Kim JH, Kim E, Lee KJ, Jeon YH, Kim EE.

Protein Sci. 2009 Nov;18(11):2265-76. doi: 10.1002/pro.237.

19.

Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response.

Götz J, David D, Hoerndli F, Ke YD, Schonrock N, Wiesner A, Fath T, Bokhari L, Lim YA, Deters N, Ittner LM.

Neurodegener Dis. 2008;5(3-4):179-81. doi: 10.1159/000113696. Epub 2008 Mar 6. Review.

PMID:
18322384
20.

Dominant-negative effect of mutant valosin-containing protein in aggresome formation.

Kitami MI, Kitami T, Nagahama M, Tagaya M, Hori S, Kakizuka A, Mizuno Y, Hattori N.

FEBS Lett. 2006 Jan 23;580(2):474-8. Epub 2005 Dec 22.

Supplemental Content

Loading ...
Support Center